Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARRY-382 |
Trade Name | |
Synonyms | |
Drug Descriptions |
ARRY-382 is a small molecule inhibitor of CSF1R, which potentially leads to decreased growth of CSF1R over expressing tumor cells (PMID: 29872489). |
DrugClasses | CSF1R Inhibitor 28 |
CAS Registry Number | 1313407-95-2 |
NCIT ID | C96227 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARRY-382 | ARRY-382 | 0 | 0 |
ARRY-382 + Pembrolizumab | ARRY-382 Pembrolizumab | 0 | 1 |